Abstract:Objective: It has been suggested that vitamin D may play a role in the pathogenesis of several endocrine diseases, such as hyperparathyroidism, type 1 diabetes (T1DM), type 2 diabetes (T2DM), autoimmune thyroid diseases, Addison's disease and polycystic ovary syndrome (PCOS). In this review, we debate the role of vitamin D in the pathogenesis of endocrine diseases. Methods: Narrative overview of the literature synthesizing the current evidence retrieved from searches of computerized databases, hand searches an… Show more
“…This hyperandrogenemia helps to preserve bone mass in PCOS women. But androgen has positive effect on bone ↑ Bone resorption Vitamin D (Muscogiuri et al 2014) 232:2 only in the presence of estrogen. Without the estradiol peak or progesterone production associated with normal menstrual cycle, there is no net positive effect for androgen on bone (Fig.…”
Section: Effect Of Androgen Excess On Bone In Pcos Womenmentioning
confidence: 99%
“…Several recent studies suggest that vitamin D is also involved in some non-skeletal actions that may lead to the pathogenesis of several endocrine diseases including PCOS (Muscogiuri et al 2014). In PCOS patients, an inverse relationship between the vitamin D status and metabolic and hormonal disturbance has been reported in PCOS (Muscogiuri et al 2014). Vitamin D influences glucose homeostasis and insulin sensitivity.…”
Section: Vitamin D Parathyroid Hormone Calcitonin and Pcosmentioning
According to the World Health Organization (WHO) polycystic ovary syndrome (PCOS) occurs in 4-8% of women worldwide. The prevalence of PCOS in Indian adolescents is 12.2% according to the Indian Council of Medical Research (ICMR). The National Institute of Health has documented that it affects approximately 5 million women of reproductive age in the United States. Hormonal imbalance is the characteristic of many women with polycystic ovarian syndrome (PCOS). The influence of various endocrine changes in PCOS women and their relevance to bone remains to be documented. Hormones, which include gonadotrophin-releasing hormone (GnRH), insulin, the leutinizing/follicle-stimulating hormone (LH/FSH) ratio, androgens, estrogens, growth hormones (GH), cortisol, parathyroid hormone (PTH) and calcitonin are disturbed in PCOS women. These hormones influence bone metabolism in human subjects directly as well as indirectly. The imbalance in these hormones results in increased prevalence of osteoporosis in PCOS women. Limited evidence suggests that the drugs taken during the treatment of PCOS increase the risk of bone fracture in PCOS patients through endocrine disruption. This review is aimed at the identification of the relationship between bone mineral density and hormonal changes in PCOS subjects and identifies potential areas to study bone-related disorders in PCOS women.
“…This hyperandrogenemia helps to preserve bone mass in PCOS women. But androgen has positive effect on bone ↑ Bone resorption Vitamin D (Muscogiuri et al 2014) 232:2 only in the presence of estrogen. Without the estradiol peak or progesterone production associated with normal menstrual cycle, there is no net positive effect for androgen on bone (Fig.…”
Section: Effect Of Androgen Excess On Bone In Pcos Womenmentioning
confidence: 99%
“…Several recent studies suggest that vitamin D is also involved in some non-skeletal actions that may lead to the pathogenesis of several endocrine diseases including PCOS (Muscogiuri et al 2014). In PCOS patients, an inverse relationship between the vitamin D status and metabolic and hormonal disturbance has been reported in PCOS (Muscogiuri et al 2014). Vitamin D influences glucose homeostasis and insulin sensitivity.…”
Section: Vitamin D Parathyroid Hormone Calcitonin and Pcosmentioning
According to the World Health Organization (WHO) polycystic ovary syndrome (PCOS) occurs in 4-8% of women worldwide. The prevalence of PCOS in Indian adolescents is 12.2% according to the Indian Council of Medical Research (ICMR). The National Institute of Health has documented that it affects approximately 5 million women of reproductive age in the United States. Hormonal imbalance is the characteristic of many women with polycystic ovarian syndrome (PCOS). The influence of various endocrine changes in PCOS women and their relevance to bone remains to be documented. Hormones, which include gonadotrophin-releasing hormone (GnRH), insulin, the leutinizing/follicle-stimulating hormone (LH/FSH) ratio, androgens, estrogens, growth hormones (GH), cortisol, parathyroid hormone (PTH) and calcitonin are disturbed in PCOS women. These hormones influence bone metabolism in human subjects directly as well as indirectly. The imbalance in these hormones results in increased prevalence of osteoporosis in PCOS women. Limited evidence suggests that the drugs taken during the treatment of PCOS increase the risk of bone fracture in PCOS patients through endocrine disruption. This review is aimed at the identification of the relationship between bone mineral density and hormonal changes in PCOS subjects and identifies potential areas to study bone-related disorders in PCOS women.
“…A correlation between AIT and reduced vitamin D action (as some polymorphisms of vitamin D receptor gene, vitamin D binding proteins, 1-and 25 hydroxylase) has also been demonstrated [16]. On the other side, type 2 deiodinase activity has been demonstrated in the mouse skeleton and is induced by vitamin D, suggesting a closer relationship between thyroid hormones and vitamin D [17].…”
Autoimmune thyroiditis and primary hyperparathyroidism are frequent diseases, mainly affecting postmenopausal women. The association between the two pathologies has been described in the literature but the underlying mechanism is not yet elucidated. We present two female patients with autoimmune thyroiditis who developed primary hyperparathyroidism. Both had normal thyroid function, high antithyroid antibodies, and high PTH and calcium values. Thyroid ultrasonography and 99m Tc-MIBI scintigraphy localized the lesion but only one patient underwent surgery. Vitamin D and selenium values were normal or slightly reduced. Both patients had osteoporosis, treated with bisphosphonates. Their evolution is, till now, satisfactory. More theories are trying to explain the correlation between autoimmune thyroiditis and primary hyperparathyroidism: the inflammatory process, the high TSH or PTH values, high calcium, low vitamin D. The possible selenium intervention would correlate environmental and genetic factors. However, all these theories are controversial and not yet proved by experimental or randomized clinical studies.
“…That the variety of phenotypes of PCOS patients and the heterogeneity of available studies make it difficult to draw conclusions and suggest the conduction of clinical trials with well-defined populations [26].…”
Introduction: Polycystic ovary syndrome (PCOS) is the most common endocrinopathyin women of reproductive age. It causes a metabolic syndrome characterized by insulin resistance, hyperinsulinemia, and dyslipidemia. Vitamin d deficiency and its association with PCOS still represents a controversial subject in the literature.Objective: In this context, this study aimed to understand the association between polycystic ovary syndrome and vitamin d deficiency, and how it occurs.
Method:It was an integrative review conducted in the PubMed, Scopus, LILACS, and CINAHL databases from August 2016 to January 2017, with a sample of 7 articles analyzed in their entirety.
Results:The evidences according to the studies conducted and the conclusions they identified.
Conclusions:It was concluded that we cannot yet assume that vitamin d deficiency contributes to the pathogenesis of PCOS, nor that the syndrome causes vitamin d deficiency, since the studies are controversial and there is a need for research with higher levels of evidence to clarify these doubts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.